A Case of Statin-Induced Rhabdomyolysis in a 45-Year-Old Patient with Chronic Kidney Disease
Abstract
Statin-induced rhabdomyolysis is a rare but potentially life-threatening condition, especially in patients with chronic kidney disease (CKD). This case report describes a 45-year-old male with CKD stage 5 who developed severe muscle pain, weakness, and dark urine after six months of atorvastatin therapy for dyslipidemia. Laboratory findings revealed markedly elevated creatine kinase (CK) levels, myoglobinemia, and myoglobinuria. Atorvastatin was immediately discontinued, and the patient received aggressive intravenous hydration. His symptoms and CK levels gradually improved without acute kidney injury. This case underscores the importance of vigilance in prescribing statins to CKD patients and highlights the need for prompt recognition and management of rhabdomyolysis. Clinicians should prioritize alternative lipid-lowering strategies for high-risk patients.Keywords:
Rhabdomyolysis, Statins, Chronic Kidney Disease, Adverse Drug Reaction.Published
2025/06/05
Issue
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments psimjournal@gmail.com